NOT KNOWN DETAILS ABOUT CDK2-IN-4

Antibodies would be the top class of therapeutics, due in large part to their ability to connect with distinctive ligand conformations to be able to elicit specific biological responses. Nevertheless, discovery of new molecules binding specific epitopes is time-consuming and challenging, specifically for cases demanding a selected antibody-ligand o